Biovision World Life Science Forum 2017

Biovision World Life Science Forum 20174 - 6 April 2017, Lyon, France.
Biovision World Life Science Forum is fostering a unique approach to meet, connect and collaborate between international decision-makers from the academic, civil society, policy-making and private sectors whether industrials or investors. Biovision being the place to network and make the connections you need to secure partnerships, investments and contacts.

Presenting an impressive line-up of participants addressing evidence and research as well as development and promotion, the 2017 edition of the Biovision life sciences forum affirms its status as a standout gathering of knowledge among other such international meetings. This year, the forum will welcome major players from the health sector representing each step of the value chain (research, innovation, partnerships and finance) with the goal of arriving at concrete solutions to existing and future health issues.

Biovision Prospective: A meeting place for stakeholders in global health
The Prospective meetings will facilitate discussions between Biovision participants, international experts and leading figures in global health and prevention throughout the course of four main session focusing on the following paths:

  • Global medical education & training
  • Digital health and innovation for sustainable healthcare
  • Emerging viral diseases
  • Animal health
  • Cancer
  • Innovative technologies and science of metagenomics to reach ONE HEALTH

During each session, twenty to thirty experts will participate and exchange ideas in workshops. Their conclusions will be presented at plenary session and finalized within the Call for action addressed to the international community at Biovision's closing ceremony.

Biovision Catalyzer: A springboard for innovative health projects and start-ups
Innovators in the fields of Biotech, Medtech and e-health may hold the solutions to the health issues of today and tomorrow. Biovision is committed to discovering these individuals, supporting them by putting their ideas in the spotlight, and placing them on the fast track towards the fulfilment and realisation of their work. During the Catalyzer meetings, these pioneers in emerging health fields will have the opportunity to pitch their proposals to an expert committee comprised of academic, industry and civil society partners for the chance to develop future collaborations as well as further implementation of their projects.

Innovators will also be more than welcome to take part in Biovision Prospective paths, to challenge, exchange and discuss with Key Opinion Leaders (KOLs) and experts, participate in the ensuing Insight sessions that will lead to Call for Actions on major health issues. They will also get to meet and exchange with KOLs during 'Coffee with' sessions.

Biovision Investor: The intersection of health start-ups and venture capital
The INVESTOR accelerates the fundraising process of Biotech, Medtech and e-health start-ups by putting them in direct contact with potential business and development partners. Selected from a pool of applicants by a special committee, start-ups with the greatest potential to offer innovative health solutions will present their pitches during the Biovision forum in front of a jury comprised of leading European private and corporate investors in the life sciences.

For furher information, please visit:
http://www.biovision.org

Most Popular Now

Mobile App Tracking Blood Pressure Helps…

The AHOMKA platform, an innovative mobile app for patient-to-provider communication that developed through a collaboration between the School of Engineering and leading medical institutions in Ghana, has yielded positive results...

Accelerating NHS Digital Maturity: Paper…

Digitised clinical noting at South Tees Hospitals NHS Foundation Trust is creating efficiencies for busy doctors and nurses. The trust’s CCIO Dr Andrew Adair, deputy CCIO Dr John Greenaway, and...

Can AI Help Detect Cognitive Impairment?

Mild cognitive impairment (MCI) can be an early indicator of Alzheimer's disease or dementia, so identifying those with cognitive issues early could lead to interventions and better outcomes. But diagnosing...

Customized Smartphone App Shows Promise …

A growing body of research indicates that older adults in assisted living facilities can delay or even prevent cognitive decline through interventions that combine multiple activities, such as improving diet...

New Study Shows Promise for Gamified mHe…

A new study published in Multiple Sclerosis and Related Disorders highlights the potential of More Stamina, a gamified mobile health (mHealth) app designed to help people with Multiple Sclerosis (MS)...

AI Tool Helps Predict Who will Benefit f…

A study led by UCLA investigators shows that artificial intelligence (AI) could play a key role in improving treatment outcomes for men with prostate cancer by helping physicians determine who...

AI in Healthcare: How do We Get from Hyp…

The Highland Marketing advisory board met to consider the government's enthusiasm for AI. To date, healthcare has mostly experimented with decision support tools, and their impact on the NHS and...

Research Shows AI Technology Improves Pa…

Existing research indicates that the accuracy of a Parkinson's disease diagnosis hovers between 55% and 78% in the first five years of assessment. That's partly because Parkinson's sibling movement disorders...

Patients' Affinity for AI Messages …

In a Duke Health-led survey, patients who were shown messages written either by artificial intelligence (AI) or human clinicians indicated a preference for responses drafted by AI over a human...

New AI Tool Accelerates Disease Treatmen…

University of Virginia School of Medicine scientists have created a computational tool to accelerate the development of new disease treatments. The tool goes beyond current artificial intelligence (AI) approaches by...

DMEA sparks: The Future of Digital Healt…

8 - 10 April 2025, Berlin, Germany. Digitalization is considered one of the key strategies for addressing the shortage of skilled workers - but the digital health sector also needs qualified...

First Therapy Chatbot Trial Shows AI can…

Dartmouth researchers conducted the first clinical trial of a therapy chatbot powered by generative AI and found that the software resulted in significant improvements in participants' symptoms, according to results...